Ethos Life Insurance Fit Review for Type 2 Diabetes

Research Snapshot

Why Ethos Life Qualified for This Study

Questions This Section Answers

• Is Ethos Life a good choice for life insurance for Type 2 diabetes?
• How many AI platforms named Ethos Life for Type 2 diabetes life insurance, and at what rank?

Ethos Life qualified because two platforms named it during ranking discovery, meeting the study's two-mention threshold. Anthropic listed it at rank 9; DeepSeek listed it at rank 1. That spread — first place on one platform and ninth on another — is the central tension in this review.

The entity also qualified on substance. Ethos maintains a diabetes-specific consumer page describing life insurance options for diabetics and the choice between fully underwritten and no-exam coverage ^[2]. It markets term life insurance with an online application ^[6] and no-medical-exam coverage ^[7]. Its partner carriers include Banner Life and TruStage ^[8], and Legal & General America's public underwriting fact sheet identifies controlled Type 2 diabetes as eligible for Standard Plus consideration in stated circumstances ^[9].

Fit ratings diverged by platform: anthropic, google, and grok rated Ethos a good fit; openai, deepseek, perplexity, and kimi rated it mixed. No platform rated it poor. That split is why this review treats Ethos as a conditional option rather than a default recommendation.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Type 2 Diabetes

Questions This Section Answers

• Which Ethos Life product should a buyer with Type 2 diabetes apply for — simplified issue or fully underwritten term?
• Does Ethos Life offer no-medical-exam term coverage for Type 2 diabetes, and how much coverage is available?

The relevant offering is Ethos term life insurance, available in two broad paths: simplified-issue/no-medical-exam term coverage and a fully underwritten term option issued by a partner carrier. Term lengths run 10 to 30 years ^[10]. Ethos publicly describes no-exam term coverage of up to $3 million ^[12], and its homepage states coverage up to $3 million with a 10-minute application (official:C1).

Ethos does not underwrite its own policies; carriers include Banner Life and TruStage ^[14]. One platform reported that Ethos term policies are issued by Legal & General America / Banner Life ^[16], and another reported a split structure — term policies up to $2 million issued by LGA and up to $500,000 issued by Ameritas ^[18]. These are platform-reported descriptions, not confirmed product structures.

The product ambiguity matters for a diabetic buyer. Ethos's public agent FAQ states that all Ethos policies are underwritten without a medical exam ^[19], which conflicts with platform descriptions of a fully underwritten Ethos term product. The exact underwriting pathway — simplified issue, accelerated underwriting, or fully underwritten — is not resolved by the reviewed sources and should be confirmed before applying.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Ethos Life for Type 2 diabetes life insurance?
• Is Ethos Life's no-exam application genuinely faster than traditional underwriting for a diabetic applicant?

Agreement was strong on process and limited on outcomes.

Online, no-exam positioning. Platforms consistently described Ethos as marketing no-medical-exam life insurance with an online application ^[21]. Ethos's own materials say the application takes as little as ten minutes and that 95% of applicants receive an instant decision ^[25].

Underwriting still happens. Platforms agreed that no exam does not mean no underwriting. Ethos states that insurers may use health questions, prescription history, medical records, and other data ^[27], and independent reviews describe reliance on prescription history, MIB records, and driving and financial data ^[29].

Diabetes is not an automatic decline. Ethos states that a medical condition does not automatically prevent term-life eligibility and that approval depends on how well the condition is managed ^[32].

Rates run above market. Multiple independent reviews reported Ethos term premiums 16% to 48% above average depending on coverage level ^[35], described as the tradeoff for skipping the exam ^[38].

Cancellation terms. Ethos states term policies can generally be cancelled without a cancellation fee, subject to policy requirements ^[40], and that cancelled term policies generally do not refund premiums ^[41]. Independent reviews describe a 30-day money-back guarantee ^[42].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Why do AI platforms disagree about whether Ethos Life is a good fit for Type 2 diabetes?
• What is unverified about Ethos Life's diabetes underwriting and approval rates?

Fit rating. Three platforms rated Ethos a good fit for stable Type 2 diabetes; four rated it mixed. The disagreement tracks how much weight each platform gave to convenience versus price and transparency.

Approval rates. One review reported approval rates as high as 94% same-day ^[44]; another reported that approval rates are much lower than advertised and that many applicants are declined or referred to more expensive fully underwritten options ^[45]. The discrepancy may reflect instant decisions, including downgrades, versus full approvals. No definitive recent study of Ethos approval rates for diabetics was located.

Coverage limits. General simplified-issue term policies typically range from $100,000 to $250,000, with applicants older than 55 frequently limited to about $100,000 ^[47]. One platform reported simplified-issue coverage up to $3 million for well-controlled Type 2 diabetics under age 60 ^[49]. Whether $3 million is achievable through simplified issue or requires a fully underwritten path is unresolved.

Knockout criteria. Platform-reported underwriting guides describe diabetes-related knockouts including diagnosis before age 30 or 40 with insulin, A1C above 9.5% in the past 12 months, no recent checkup, BMI above a threshold, and complications such as neuropathy, kidney issues, retinopathy, or amputations ^[50]. These are platform-reported from third-party documents, not confirmed by Ethos.

Carrier assignment. One platform reported that because Ethos assigns the carrier, buyers cannot compare pricing across multiple insurers ^[54]. Another reported that qualified applicants can receive up to $5 million through Banner Life's accelerated underwriting program without a medical exam ^[55].

Stale evidence. One independent review dated January 2022 conflicts with more recent 2026 sources on approval rates and marketing accuracy. No 2026 study of actual Ethos approval rates for diabetics was located.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features does Ethos Life offer that matter to a buyer with Type 2 diabetes?
• Does Ethos Life's automatic product ladder protect a diabetic applicant from being declined?

Online application. Ethos says applications are online, can be completed in minutes, and may produce same-day coverage for some customers ^[56]. One platform described Ethos as one of the fastest providers for instant-decision no-medical-exam policies ^[57].

Data-driven underwriting. Independent reviews describe accelerated underwriting that pulls prescription history, MIB records, and driving and financial data rather than sending a nurse ^[58]. Ethos states its underwriting can use health questions verified through health history, prescriptions, and records ^[61].

Automatic product ladder. Platform-reported reviews describe a laddering system that moves applicants to the next-best policy option rather than declining outright — from Term Life Prime to Term Life Choice, then Advantage Whole Life, then Guaranteed Acceptance Whole Life ^[62]. One review noted this may come with higher premiums ^[66].

Diabetes-relevant underwriting factors. Ethos identifies A1C trends, age at diagnosis, treatment method, complications, and related conditions such as blood pressure or cholesterol as rating factors ^[67]. Its diabetes guidance recommends preparing diagnosis date, latest A1C, medications, and complication history ^[69].

GLP-1 medications. One independent review reported that some insurers now view GLP-1 medications as a positive sign of proactive diabetes management when paired with improved A1C and stable health ^[70]. This is a general market observation, not an Ethos-specific underwriting rule.

Carrier financial strength. One review reported that all four partner carriers carry A.M. Best ratings from A (Excellent) to A+ (Superior) ^[71].

Riders and exclusions. One review reported that policy riders and additional coverage options may be limited compared with traditional insurers, and that specific exclusions such as suicide within the first two years apply ^[72].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Ethos Life cost per month for a buyer with Type 2 diabetes, and are there setup or cancellation fees?
• Is Ethos Life cheaper or more expensive than fully underwritten life insurance for a diabetic applicant?

No reliable individualized premium can be stated for a Type 2 diabetes applicant. Ethos publishes illustrative averages and calculator estimates but states that actual premiums vary by state, health profile, and coverage selection ^[74]. Ethos's terms state that the quote is not the final price and that the price is not final until the contract is signed and the initial premium paid (official:C2).

Independent reviews reported Ethos term premiums 16% to 48% above national average depending on coverage level and gender ^[75]. One platform reported sample rates for a 40-year-old nonsmoker: $250,000 / 20-year term at roughly $21–35 per month; $750,000 / 20-year term at roughly $40–72; $2 million / 20-year term at roughly $99–178; and $3 million / 20-year term at roughly $145–365 (anthropic pricing summary). These are platform-reported illustrative figures, not quotes for a diabetic applicant.

On fees, one platform reported no separate Ethos application fee was identified in reviewed public materials, and that any policy fee, rider charge, or carrier-specific fee should be confirmed in the quote and policy documents (openai pricing summary). Ethos's terms state that premiums quoted may include an annual policy fee, which is subject to change prior to policy issue but will not increase or decrease once issued (official:C2).

On cancellation, Ethos states term policies can generally be cancelled without a cancellation fee, subject to policy requirements ^[78], and that cancelled term policies generally do not refund premiums ^[79]. Independent reviews describe a 30-day money-back guarantee returning premiums paid within the first month, with cancellation allowed without penalty afterward but no refund of prior payments ^[80]. Ethos's terms state that policies can be returned without obligation within 30 days of receipt in most states, and that two-year contestability and suicide provisions may apply (official:C2).

Pricing confidence across platforms was low to moderate. No platform established a diabetes-specific surcharge or guaranteed rate class.

Best Suited For

Questions This Section Answers

• Who is Ethos Life best suited for when shopping for life insurance with Type 2 diabetes?
• Is Ethos Life worth it for a diabetic buyer who prioritizes speed over the lowest premium?

Ethos is best suited for applicants who prioritize a fast, online, no-medical-exam application over the lowest possible premium. Platform fit assessments converged on several buyer profiles:

• Adults with stable, well-controlled Type 2 diabetes, limited complications, and moderate coverage needs (openai fit assessment, anthropic fit assessment).
• Applicants who want to avoid a medical exam or blood draw ^[83].
• First-time buyers who prefer an all-online application process (anthropic fit assessment).
• Applicants who may qualify for simplified issue and want a decision without weeks of waiting ^[84].
• Buyers who value automatic reassessment into another product rather than an outright decline ^[86].

One platform framed the value differently: buyers already favorable to Banner Life underwriting who want Ethos's online platform as an intermediary (kimi fit assessment). Another emphasized applicants managing diabetes with lifestyle or oral medications such as metformin (google fit assessment).

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Ethos Life for life insurance with Type 2 diabetes?
• Does Ethos Life work for insulin-dependent or complicated Type 2 diabetes cases?

Ethos is probably not the best route for buyers seeking the lowest possible premium through comparison among multiple diabetes-friendly carriers (openai fit assessment). Several other profiles recur across platform assessments:

• Applicants with elevated or unstable A1C, insulin use, diabetes complications, or other significant health conditions who need specialized brokerage underwriting (openai fit assessment, anthropic fit assessment).
• Applicants with complications such as neuropathy, retinopathy, nephropathy, or cardiovascular disease ^[89].
• Applicants with recent diabetes diagnoses or unstable A1C or medication changes (anthropic fit assessment).
• Applicants over 60 seeking term coverage, who may be redirected to more expensive whole life ^[90].
• Applicants needing coverage above $3 million through simplified issue (anthropic fit assessment).
• Buyers who need guaranteed-issue coverage regardless of health (deepseek fit assessment, kimi fit assessment).
• Buyers who want fully disclosed, fixed pricing before applying (perplexity fit assessment).
• Applicants diagnosed under age 30 or with A1C above 9.5% in the past 12 months, per platform-reported knockout criteria ^[89].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Ethos Life for a Type 2 diabetes buyer who needs lower premiums or broader carrier comparison?
• When should a diabetic buyer use an independent broker instead of Ethos Life?

Platforms identified several situations where another route may serve a diabetic buyer better.

When A1C is elevated, complications exist, or a prior application was declined. Use an independent broker with access to multiple carriers (openai better_alternative_when). Brokerage value increases as the number of underwriting variables increases ^[92].

When the buyer wants the lowest possible premium. Fully underwritten policies from carriers such as Banner Life or Nationwide often offer lower term rates (anthropic better_alternative_when). One platform noted that healthy diabetics with excellent management might secure lower long-term premiums through traditional manual underwriting ^[93].

When the buyer wants diabetes-specific programs. John Hancock Aspire provides up to 25% premium savings for diabetics via Vitality PLUS with diabetes-specific wellness support ^[95]. One platform reported Banner Life is most aggressive for well-controlled Type 2 diabetes with Standard Plus Non-Tobacco rates ^[96].

When the buyer needs guaranteed issue. Mutual of Omaha guaranteed issue whole life was named as an option for insulin-dependent or complicated cases ^[97].

When the buyer wants published underwriting criteria. One platform recommended carriers with published diabetic underwriting guidelines and A1C-specific criteria (deepseek better_alternative_when). Another recommended applying directly to Banner Life for published Standard Plus rates and underwriting transparency (kimi better_alternative_when).

When the buyer needs permanent coverage or higher limits. Consider specialized permanent-life carriers or guaranteed-issue options only when term coverage is unavailable or lifelong coverage is required; these may cost more or offer less coverage (openai better_alternative_when).

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Ethos Life before signing a Type 2 diabetes life insurance contract?
• Which carrier will issue the Ethos Life policy, and what underwriting class applies?

Platforms converged on a verification checklist. Confirm the issuing carrier — whether Banner Life, another Legal & General America company, Ameritas, TruStage, or a different carrier ^[98]. Confirm whether the application is simplified issue, accelerated underwriting, or fully underwritten, and whether a medical exam, labs, or an attending physician statement can be requested (openai questions, deepseek questions).

Confirm how the insurer will evaluate diagnosis age, latest and historical A1C, glucose control, insulin or other medications, diabetic complications, kidney or cardiovascular findings, weight, and physician follow-up (openai questions, perplexity questions). Ask what underwriting class and final premium are offered after prescription, medical-record, and database checks (openai questions, anthropic questions).

Confirm maximum coverage amount, available term lengths, issue-age limits, and state-specific restrictions (openai questions, anthropic questions). One platform noted Ethos is not available in New York (anthropic questions). Confirm whether the policy includes conversion to permanent insurance, until what age or date, and any conversion restrictions (openai questions, anthropic questions).

Confirm annual policy fees, rider costs, renewal premiums, free-look period, contestability period, and cancellation consequences (openai questions, anthropic questions). Ask whether applying through an independent broker would expose the buyer to a better-priced or more suitable carrier before accepting the Ethos offer (openai questions).

Final AI Consensus Verdict

Ethos Life is a mixed fit for an adult with reasonably stable Type 2 diabetes. Two of seven platforms named it during ranking discovery, with an average listed rank of 5.0 and a best listed rank of 1. Three platforms rated it a good fit; four rated it mixed.

The case for Ethos rests on convenience and potential carrier access: an online application, no-medical-exam marketing, and possible placement with Banner Life / Legal & General America, whose public fact sheet places controlled Type 2 diabetes in Standard Plus consideration in stated circumstances ^[99]. The case against rests on opacity and price: no published diabetes-specific underwriting table, no confirmed A1C thresholds, no confirmed premium for this buyer, platform-reported rates 16% to 48% above average, and unresolved conflicts about approval rates, coverage limits, and whether the relevant product is simplified issue or fully underwritten.

A buyer with well-controlled Type 2 diabetes who values speed should compare Ethos against fully underwritten quotes from multiple carriers before accepting an offer. A buyer with complications, insulin dependence, or less stable control should generally start with an independent broker. Platform agreement on Ethos's convenience does not establish that Ethos offers the best price or the most favorable underwriting outcome for any individual diabetic applicant.

How This Review Was Produced

This review evaluates Ethos Life only for the use case of Life Insurance for Type 2 Diabetes. It is not a broad company review. Seven AI platforms were queried with the same buyer prompt: an adult with Type 2 diabetes who wants life insurance and is otherwise in reasonably stable health, understanding that underwriting may consider age at diagnosis, A1C and glucose control, medications or insulin use, complications, weight, medical follow-up, and other health factors.

Two platforms named Ethos Life during the ranking stage, meeting the study's two-mention threshold. All seven platforms supplied fit-research responses, which were used for the qualitative sections. Fit ratings, product descriptions, pricing summaries, and verification questions are drawn from those platform responses and their cited sources.

The study date is 2026-09-22. Platform-reported research dates are provenance metadata and do not independently prove freshness. All included platforms evaluated fit, but platform mentions count only platforms that named the entity during ranking discovery. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts.

Methodology Limitations

Several limitations apply to this review.

No independent verification. No platform's claims were independently verified. Company-owned sources describe Ethos's own products and processes; independent sources are third-party reviews and directories. Neither category was audited by the writer stage.

Product ambiguity. Ethos's public agent FAQ states all policies are underwritten without a medical exam ^[100], conflicting with platform descriptions of a fully underwritten Ethos term product issued by Legal & General America / Banner Life. The reviewed sources do not independently verify that every Ethos applicant is offered Banner Life or Legal & General America.

No diabetes-specific pricing. Public Ethos pages provide general diabetes guidance and illustrative pricing, not binding eligibility rules or individualized quotes. No platform established a diabetes-specific surcharge or guaranteed rate class.

Unresolved coverage limits. Simplified-issue coverage limits for diabetics were stated as both up to $250,000 generally and up to $3 million for well-controlled Type 2 diabetics under 60. Whether $3 million is achievable through simplified issue or requires a fully underwritten path is unresolved.

Conflicting approval-rate evidence. One review reported approval rates as high as 94% same-day; another reported approval rates much lower than advertised. One independent review dated January 2022 conflicts with more recent 2026 sources. No definitive recent study of Ethos approval rates for diabetics was located.

Platform-reported dates differ from the run date. DeepSeek reported a research date of 2026-06-01; the authoritative run research date is 2026-09-22. DeepSeek also ran without search enabled, so its claims are model-reported rather than retrieved.

Knockout criteria are platform-reported. Diabetes-related knockout conditions described in this review come from third-party documents cited by platforms, not from confirmed Ethos underwriting rules. No published Ethos-specific data shows what A1C threshold, medication type, or complication level triggers a downgrade to whole life versus term approval.

No personal testing. No platform or writer tested Ethos's application process, underwriting outcomes, or customer experience for a Type 2 diabetes applicant.